EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Impact of the Normalized Copy Number of <i>BCR-ABL</i> Transcript upon Diagnosis on Prognosis in CML Patients Treated with Imatinib-Mesylate

Christophe Martinaud, Aurélie Mayet, Sophie Bousquet, Nathalie Beaufils, Jean Gabert, Sophie Raynaud, Marie-Joelle Mozziconacci

Open Journal of Blood Diseases · 2011

DOI: 10.4236/ojbd.2011.12004 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Open Journal of Blood Diseases, 2011. Verfasst von Christophe Martinaud und 6 weiteren Autor:innen. Die Arbeit nennt 8 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Martinaud, C., Mayet, A., Bousquet, S., Beaufils, N., Gabert, J., Raynaud, S., & Mozziconacci, M. (2011). Impact of the Normalized Copy Number of BCR-ABL Transcript upon Diagnosis on Prognosis in CML Patients Treated with Imatinib-Mesylate. Open Journal of Blood Diseases. https://doi.org/10.4236/ojbd.2011.12004

Vancouver

Martinaud C, Mayet A, Bousquet S, Beaufils N, Gabert J, Raynaud S, et al. Impact of the Normalized Copy Number of BCR-ABL Transcript upon Diagnosis on Prognosis in CML Patients Treated with Imatinib-Mesylate. Open Journal of Blood Diseases. 2011. doi:10.4236/ojbd.2011.12004

BibTeX
@article{Martinaud2011,
  author = {Martinaud, Christophe and Mayet, Aurélie and Bousquet, Sophie and Beaufils, Nathalie and Gabert, Jean and Raynaud, Sophie and Mozziconacci, Marie-Joelle},
  title = {Impact of the Normalized Copy Number of BCR-ABL Transcript upon Diagnosis on Prognosis in CML Patients Treated with Imatinib-Mesylate},
  journal = {Open Journal of Blood Diseases},
  year = {2011},
  doi = {10.4236/ojbd.2011.12004}
}
Kostenlos starten →